PIXAREM Trademark
Serial Number: 79267458 • Registration: 6098378
PIXAREM is a trademark filed by
GUERBET
on July 16, 2019. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Dianne M. Smith-Misemer Hovey Williams LLP
10801 Mastin Boulevard, Suite 1000
Overland Park, KS 66210
UNITED STATES
Trademark Details
Filing Date
July 16, 2019
Registration Date
July 14, 2020
Published for Opposition
April 28, 2020
Goods & Services
Imaging agents and contrast media for magnetic resonance imaging (MRI)
Filing History
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 14, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 4, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 3, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 14, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 14, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2020 CRFA
ASSIGNED TO LIE
Mar 16, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2020 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 4, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 4, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 12, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 11, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 10, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 2, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 1, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 1, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 27, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 19, 2019 REPR
